Synaptic Imaging Assay Service
In the quest to understand the intricate workings of the brain, accurate synaptic analysis is paramount. Our synaptic imaging assay service provides a groundbreaking solution for researchers delving into cognitive mechanisms, learning behaviors, and neurodegenerative diseases. By combining state-of-the-art imaging technology with highly specific markers, we offer unparalleled precision and clarity in visualizing and quantifying synaptic function. For further information regarding the products and services provided, project-specific consultation, and pricing, please submit an inquiry here.
Our Synaptic Imaging Assays
Our services are based on in vitro neuronal models (mouse/rat hippocampal neurons, human iPSC-derived neurons) and use multiple fluorescent labeling and super-resolution imaging technology to accurately measure the following parameters
- Synapse Type Identification
Excitatory synapses: VGLUT1 (vesicular membrane protein) and PSD95 (postsynaptic marker) labeling.
Inhibitory synapses: Specific labeling with GAD65 (glutamate decarboxylase).
Supports Synaptobrevin2 (vesicle membrane anchor protein) detection to quantify the number, size and strength of synapses.
Fig.1 Fluorescence image of DA neurons (day 55) immunolabeled with VGLUT2 (green) and synapsin (magenta) antibodies.1, 3
- Dynamic Functional Assessment
Synaptic strength: Combined with Synapsin IIa (vesicle aggregation protein) labeling to analyze the structural stability of synaptic active zones.
Ratio analysis: Calculate the balance of inhibitory/excitatory synapses to reveal changes in neural circuit plasticity.
Fig.2 vGluT1/GAT1 ratios.2, 3
Why Choose Us
![]() |
![]() |
Our service provides a multivariate analysis of synaptic activity, extending beyond standard mEPSC detection. It simultaneously resolves synaptic identity (excitatory/inhibitory), quantifies synaptic strength, and maps spatial distribution, enabling detailed investigation of complex neuronal mechanisms. | Our service supports cross-level research, facilitating validation across in vitro neuronal cultures and in vivo humanized mouse models, thereby streamlining preclinical translation. |
Application
Our advanced synaptic imaging services are instrumental in driving research across critical neurological domains:
- Cognitive and Learning Sciences: We illuminate the synaptic mechanisms underlying learning and memory by precisely quantifying changes in synaptic density, type, and distribution.
- Neurodegenerative Disease Research: In conditions like Alzheimer's (AD) and Parkinson's (PD), our platform enables the detection of subtle synaptic loss and dysfunction, providing crucial insights for disease diagnosis, progression monitoring, and therapeutic development.
- Pharmaceutical Development: We accelerate drug discovery by providing robust assessments of candidate drug effects on synaptic function, facilitating rapid and accurate screening and efficacy evaluation.
Our team consists of experienced neuroscientists and technical experts who can provide comprehensive support, ranging from experimental design to data analysis. We invite you to visit our official website or contact our customer service team to learn more about our synaptic imaging assay service. We are eager to collaborate with you to advance the field of neuroscience research and drug development.
References
- Fujise, Kenshiro, et al. "Synaptic vesicle characterization of iPSC-derived dopaminergic neurons provides insight into distinct secretory vesicle pools." npj Parkinson's Disease 11.1 (2025): 16.
- Lauterborn, Julie C., et al. "Increased excitatory to inhibitory synaptic ratio in parietal cortex samples from individuals with Alzheimer's disease." Nature communications 12.1 (2021): 2603.
- Distributed under Open Access license CC BY 4.0, without modification.

- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- iNeuMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- Mouse Midbrain Dopaminergic Neuron Cell MN9D (Cat#: NCL2110P059)
- Green Fluorescent BACE1 Cell Lines (Cat#: NCL2110P214)
- Green Fluorescent Alpha-synuclein Cell Line (Cat#: NCL2110P209)
- iNeu™ Human Neural Stem Cell Line (Cat#: NCL200552ZP)
- iNeu™ Human Oligodendrocyte Progenitor Cells (OPCs) (Cat#: NCL-2103-P49)
- Human Brain Astroblastoma U-87 MG (Cat#: NCL2110P117)
- Human Brain Microvascular Endothelial Cells (Cat#: NCL-2103-P133)
- iNeu™ Human Motor Neurons (Cat#: NCL-2103-P71)
- Human Dental Pulp Stem Cells (Cat#: NRZP-1122-ZP113)
- Human Microglia Cell Line HMC3, Immortalized (Cat#: NCL-2108P38)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)